StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The stock has a market cap of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90. Athersys has a one year low of $0.01 and a one year high of $1.99.
Athersys Company Profile
See Also
- Five stocks we like better than Athersys
- How to buy stock: A step-by-step guide for beginners
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Dividend Payout Ratio Calculator
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- How to Invest in the FAANG Stocks
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.